Back to Search
Start Over
Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
- Source :
-
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2007 Oct; Vol. 27 (8), pp. 1045-55. - Publication Year :
- 2007
-
Abstract
- Background/aim: Anandamide can activate potassium (K(+)) channels to induce an endothelium-dependent vasorelaxation in normal rat mesenteric arteries. Cannabinoids contribute partly to the splanchnic vasodilation in cirrhosis. This study investigated the roles of vascular K(+) channels in anandamide-induced mesenteric vasorelaxation in isolated rat cirrhotic vessels.<br />Methods: The effects of the pretreatment of AM251, a specific CB(1) receptor antagonist, were assessed on the vascular reactivity to phenylephrine (PE), potassium chloride (KCl), acetylcholine (ACh) and sodium nitroprusside (SNP). Additionally, cannabinoid (CB(1) and CB(2)) receptors' protein expression and the effects of different K(+) channel blockers on vascular reactivity to anandamide were also studied.<br />Results: Cirrhotic mesenteric arteries showed an overexpression of CB(1) receptor associated with hyporeactivity to PE and KCl, and hyper-response to ACh, SNP and anandamide. Pretreatment with AM251 significantly improved the hyporeactivity to KCl and ameliorated the hyper-response to ACh in cirrhotic vessels. Increased relaxation response to anandamide was suppressed by combinations of vascular Ca(2+)-dependent K(+) channel blockers (including apamin+charybdotoxin+iberiotoxin or apamin+TRAM-34+iberiotoxin) (TRAM-34, 1-[(2-chlorophenyl)diphenylmethyl]-1H-pyrazole).<br />Conclusions: In cirrhotic mesenteric arteries, vascular CB(1) receptor and anandamide contribute to the in vitro hyporeactivity to KCl. In addition, hyper-response to ACh may probably act through the modulation of vascular Ca(2+)-dependent K(+) channels.
- Subjects :
- Acetylcholine pharmacology
Animals
Apamin pharmacology
Charybdotoxin pharmacology
Common Bile Duct surgery
Dose-Response Relationship, Drug
Endocannabinoids
Glyburide pharmacology
Ligation
Liver Cirrhosis, Biliary physiopathology
Liver Cirrhosis, Experimental physiopathology
Male
Mesenteric Artery, Superior drug effects
Mesenteric Artery, Superior physiopathology
Nitroprusside pharmacology
Peptides pharmacology
Phenylephrine pharmacology
Piperidines pharmacology
Potassium Channel Blockers pharmacology
Potassium Channels, Calcium-Activated antagonists & inhibitors
Potassium Chloride pharmacology
Pyrazoles pharmacology
Rats
Rats, Sprague-Dawley
Receptor, Cannabinoid, CB1 antagonists & inhibitors
Receptor, Cannabinoid, CB1 metabolism
Receptor, Cannabinoid, CB2 metabolism
Vasoconstrictor Agents pharmacology
Vasodilator Agents pharmacology
Arachidonic Acids metabolism
Cannabinoid Receptor Modulators metabolism
Liver Cirrhosis, Biliary metabolism
Liver Cirrhosis, Experimental metabolism
Mesenteric Artery, Superior metabolism
Polyunsaturated Alkamides metabolism
Potassium metabolism
Potassium Channels, Calcium-Activated metabolism
Vasodilation drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1478-3223
- Volume :
- 27
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Liver international : official journal of the International Association for the Study of the Liver
- Publication Type :
- Academic Journal
- Accession number :
- 17845532
- Full Text :
- https://doi.org/10.1111/j.1478-3231.2007.01551.x